RxDoctor Payments Data

Donald Griffith

Urology · Houston, TXNPI 1821102930

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $731,388 of the $731,663 with a category attached, or 100.0%. Mission Pharmacal Company accounts for 100.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $183,557 and has fallen 56.3% since, to $80,264 in 2025. Among urology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$731,663in general payments, 2019–2025

Across 34 payments — averaging $21,520 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mission Pharmacal Company$731K
  • Boston Scientific$163
  • Endo Pharmaceuticals Inc.$35
  • Medtronic$33
  • Photocure Inc$25
  • Ambu Inc.$19

What the payments were for

  • Royalty or licence$731,388100%
  • Grants$730%
  • Food & beverage$2020%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$731,663 in reported general payments places this provider in the 95th percentile of 878 urology providers in Texas.

See all urology providers in Texas

Other urology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →